MedTrace Logo

Evaluation of Advanced US Tools in Assessing Allograft Complications

NCT04423458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-02-08

No results posted yet for this study

Summary

This study evaluates the role of advanced US technology in assessing renal transplants as screening tools such as 3D Ultrasound, Ultrasound SWE, and MFI besides current ultrasound conventional metheds.

Conditions

  • Renal Failure
  • Chronic Kidney Diseases
  • Failure,Kidney
  • Renal Artery Stenosis
  • Fibrosis
  • Complications

Interventions

DEVICE

3D imaging

The study will focus on the accuracy of ultrasound technology in assessing renal transplants. The entire assessment should not take more than 25 minutes.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Mohammed Aslam, PhD · Academic Supervisor

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-04
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04423458 on ClinicalTrials.gov